SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001469709-18-000120
Filing Date
2018-07-06
Accepted
2018-07-06 17:04:48
Documents
2
Period of Report
2018-07-06
Effectiveness Date
2018-07-06

Document Format Files

Seq Description Document Type Size
1 AGGX DEF 14A 07/06/18 aggxsch14a_070618apg.htm DEF 14A 97729
2 GRAPHIC aggxsch14a_070618apg002.gif GRAPHIC 31860
  Complete submission text file 0001469709-18-000120.txt   142826
Mailing Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017
Business Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017 212-874-6608
AngioGenex, Inc. (Filer) CIK: 0001085596 (see all company filings)

IRS No.: 860945116 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26181 | Film No.: 18942969
SIC: 2834 Pharmaceutical Preparations